Clinical Trial Update: Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluated tumor necrosis factor in patients undergoing surgery for various primary or metastatic cancers, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Liver Cancer
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Adrenocortical Carcinoma, Breast Cancer | EARLY_Phase 1 | Status: COMPLETED